Zydus Lifesciences Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ZYDUSLIFE BSE: 532321

₹1139.00

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #4 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited (this stock)	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹120,720 Cr

EV / EBITDA

22.4x

EV / Sales

10.26x

Market cap / Sales

9.65x

Earnings yield

3.07%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 2,996 Cr, up 9.1% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 340 Cr, down 11.7% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	2,872	456	340	₹3.3800
March 31, 2026	3,741	2,111	1,722	₹17.1100
Dec. 31, 2025	2,284	352	296	₹2.9500
Sept. 30, 2025	2,871	1,444	1,157	₹11.4900
June 30, 2025	2,588	475	385	₹3.8200
March 31, 2025	5,820	3,675	2,814	₹27.9600
Dec. 31, 2024	2,516	497	471	₹4.6800
Sept. 30, 2024	2,621	1,039	790	₹7.8500
June 30, 2024	4,160	2,234	1,701	₹16.9000
March 31, 2024	3,332	1,685	1,405	₹13.8900
Dec. 31, 2023	2,371	574	450	₹4.4500
Sept. 30, 2023	2,159	968	805	₹7.9600
June 30, 2023	2,956	1,012	781	₹7.7100

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	2,996	4,236	2,757	3,413	2,745	6,005	2,593	2,947	4,267	3,694	2,478	2,694	3,038
Operating revenue	2,872	3,741	2,284	2,871	2,588	5,820	2,516	2,621	4,160	3,332	2,371	2,159	2,956
Other income	124	495	474	542	157	185	78	327	107	361	107	534	82
Operating expenses	2,285	1,752	2,085	1,719	2,003	2,047	1,867	1,678	1,787	1,763	1,672	1,510	1,815
Operating profit	587	1,989	199	1,152	585	3,773	648	942	2,373	1,569	699	649	1,141
Operating profit margin	20.4%	53.2%	8.7%	40.1%	22.6%	64.8%	25.8%	36.0%	57.0%	47.1%	29.5%	30.1%	38.6%
Depreciation	152	151	144	136	130	128	132	134	131	131	128	125	121
Interest	103	116	116	114	138	155	97	96	115	106	104	91	90
Exceptional items, gain / (loss)	—	-107	-60	—	—	—	—	—	—	-9	—	—	—
Profit before tax	456	2,111	352	1,444	475	3,675	497	1,039	2,234	1,685	574	968	1,012
Tax	116	389	56	287	90	861	27	250	533	280	124	163	232
Net profit	340	1,722	296	1,157	385	2,814	471	790	1,701	1,405	450	805	781
EPS	3.38	17.11	2.95	11.49	3.82	27.96	4.68	7.85	16.90	13.89	4.45	7.96	7.71
Net profit (TTM)	3,515	3,560	4,652	4,826	4,459	5,775	4,366	4,346	4,361	3,442	2,527	2,332	1,979
EPS (TTM)	34.93	35.37	46.22	47.95	44.31	57.39	43.32	43.09	43.20	34.01	24.97	23.05	19.54

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	11,484	4,382	3,560
March 31, 2025	15,116	7,445	5,775

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	11.1%	10.8%	13,152^†	15,812^†	11,904^†	9,594^†	8,161^†	7,869^†	7,561^†	7,104^†	6,030^†	4,932^†
Operating revenue	8.3%	8.1%	11,484	15,116	10,819^†	9,046^†	7,982^†	7,790^†	6,687^†	6,493^†	5,823^†	4,347^†
Other income	—	—	1,668^†	696^†	1,085^†	548^†	179^†	79^†	874^†	612^†	208^†	584^†
Operating expenses	—	—	7,559^†	7,380^†	6,760^†	6,592^†	6,064^†	5,471^†	5,103^†	4,707^†	—	3,824^†
Operating profit	16.9%	11.1%	3,925^†	7,736^†	4,059^†	2,454^†	1,918^†	2,319^†	1,584^†	1,786^†	—	523^†
Operating profit margin	—	—	34.2%^†	51.2%^†	37.5%^†	27.1%^†	24.0%^†	29.8%^†	23.7%^†	27.5%^†	—	12.0%^†
Depreciation	—	—	561^†	524^†	504^†	489^†	479^†	451^†	392^†	350^†	—	256^†
Interest	—	—	483^†	464^†	391^†	278^†	135^†	71^†	192^†	119^†	64^†	19^†
Exceptional items, gain / (loss)	—	—	-167^†	0^†	-9^†	-204^†	-319^†	-188^†	-52^†	0^†	0^†	0^†
Profit before tax	29.2%	21.0%	4,382	7,445	4,240^†	2,032^†	1,164^†	1,688^†	1,822^†	1,928^†	1,497^†	817^†
Tax	—	—	822^†	1,670^†	798^†	503^†	306^†	212^†	227^†	326^†	406^†	18^†
Net profit	32.5%	19.2%	3,560	5,775	3,442^†	1,529^†	858^†	1,476^†	—	1,602^†	1,091^†	799^†
EPS	32.9%	19.7%	35.37^†	57.39^†	34.01^†	15.07^†	8.38^†	14.42^†	15.57^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	34.2%^†	51.2%^†	37.5%^†	27.1%^†	24.0%^†	29.8%^†	23.7%^†	27.5%^†	—	12.0%^†
EBIT margin	42.4%^†	52.3%^†	42.8%^†	25.5%^†	16.3%^†	22.6%^†	30.1%^†	31.5%^†	26.8%^†	19.2%^†
PBT margin	38.2%	49.2%	39.2%^†	22.5%^†	14.6%^†	21.7%^†	27.2%^†	29.7%^†	25.7%^†	18.8%^†
Net margin	31.0%	38.2%	31.8%^†	16.9%^†	10.7%^†	18.9%^†	—	24.7%^†	18.7%^†	18.4%^†
Interest coverage	10.07x^†	17.05x^†	11.85x^†	8.30x^†	9.63x^†	24.82x^†	10.46x^†	17.15x^†	24.43x^†	44.01x^†
Dividend payout	31.1%^†	5.2%^†	17.6%^†	16.6%^†	41.8%^†	0.0%^†	45.0%^†	—	—	—
Earnings retention	68.9%^†	94.8%^†	82.4%^†	83.4%^†	58.2%^†	100.0%^†	55.0%^†	—	—	—
Current ratio	2.91x	1.95x	—	—	—	—	—	—	—	—
Quick ratio	2.52x	1.70x	—	—	—	—	—	—	—	—
Debt to equity	0.31x	0.39x	—	—	—	—	—	—	—	—
Return on equity	15.0%	27.3%	—	—	—	—	—	—	—	—
Return on assets	10.5%	17.9%	—	—	—	—	—	—	—	—
Return on capital employed	17.2%^†	32.3%^†	—	—	—	—	—	—	—	—
Asset turnover	0.34x	0.47x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	2,234	570	-2,580	899	1,335
March 31, 2025	3,114	-4,504	1,384	905	2,209

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	33,880	23,672	23,571	3,198	4,233	16,252	5,593	327	5,011	2,178
March 31, 2025	32,317	21,190	21,090	5,477	2,862	15,315	7,851	103	4,136	1,952

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.